Skip to content
Find a Provider
Kevin C. Bylund, M.D.

Kevin C. Bylund, M.D.

Ovarian Cancer , Radiation Oncology , Cancer

4.9 out of 5 stars
409 Ratings
49 Comments
UR Medicine Faculty The University of Rochester Medical Faculty Group (URMFG) consists of over 900 specialist and primary care providers spanning 19 departments. URMFG is certified by the National Committee for Quality Assurance.
Accountable Health Partner Accountable Health Partners (AHP) is a network of over 2,000 community and UR medical faculty and a dozen leading hospitals throughout the region. AHP offers a full range of care.
Accepting New Patients

Contact

Appointment (585) 275-2171
Appointment (585) 475-8700
Fax (585) 341-8469
Fax (585) 275-1531

Locations

Wilmot Cancer Center - Rochester

Strong Memorial Hospital
90 Crittenden Boulevard
Rochester, NY 14642

(585) 275-5830 Get Directions
Wilmot Cancer Institute - Rochester

Highland Hospital
1000 South Avenue
Rochester, NY 14620

Get Directions

About Me

While in training, I found great fulfillment in caring for patients with cancer, seeing their strength and resolve and trying to match this in my determination to give them the best possible treatment.

I was particularly attracted to radiation oncology due to my background in physics and the...
While in training, I found great fulfillment in caring for patients with cancer, seeing their strength and resolve and trying to match this in my determination to give them the best possible treatment.

I was particularly attracted to radiation oncology due to my background in physics and the multitude of options radiation provides to treat patients with cancer. I have special interests in brachytherapy (low-dose and high-dose rates), as well as the protection of normal tissue during radiation therapy.

Since I believe all patients have unique stories to tell, my goal is to understand their individual stories – and then to discuss and tailor their radiation and cancer care. I love my work and feel privileged to support patients during the very difficult – and often rewarding – time of cancer treatment and follow-up.

Conditions I Treat

- Genitourinary cancers (prostate, bladder, kidney, testicular, etc.)
- Gynecologic cancers (endometrial, cervical, etc.)
- General radiation oncology

Faculty Appointments

Associate Professor - Department of Radiation Oncology (SMD)

Credentials

Residency & Fellowship

Residency, Radiation Oncology, University of Rochester Medical Center. 2009 - 2013

Internship, Internal Medicine, St. Louis University School of Medicine/Medical Center. 2008 - 2009

Education

MD | University of Rochester School of Medicine/Dentistry (USA). 2008

Awards

Educator of the Year. 2015

RSNA Roentgen Resident/Fellow Research Award. 2012

RSNA Roentgen Resident/Fellow Research Award. 2008

Research

Clinical Trials

Parallel Phase III Randomized Trials for High Risk Prostate Cancer Evaluating De-Intensification for Lower Genomic Risk and Intensification of Concurrent Therapy for Higher Genomic Risk With Radiation (PREDICT-RT*)

Lead Researcher: Kevin Charles Bylund

This phase III trial compares less intense hormone therapy and radiation therapy to usual hormone therapy and radiation therapy in treating patients with high risk prostate cancer and low gene risk score. This trial also compares more intense hormone...

Publications

Journal Articles

Use of angiotensin converting enzyme inhibitors is associated with reduced risk of late bladder toxicity following radiotherapy for prostate cancer

Kerns SL; Amidon Morlang A; Lee SM; Peterson DR; Marples B; Zhang H; Bylund K; Rosenzweig D; Hall W; De Ruyck K; Rosenstein BS; Stock RG; Gómez-Caamaño A; Vega A; Sosa-Fajardo P; Taboada-Valladares B; Aguado-Barrera ME; Parker C; Veldeman L; Fonteyne V; Bultijnck R; Talbot CJ; Symonds RP; Johnson K; Rattay T; Webb A; Lambrecht M; de Ruysscher D; Vanneste B; Choudhury A; Elliott RM; Sperk E; Herskind C; Veldwijk MR; Rancati T; Avuzzi B; Valdagni R; Azria D; Farcy Jacquet MP; Chang-Claude J; et al.

Radiother Oncol. 2022; 168: 75-82.

Radiologically occult lung cancer curatively treated with high-dose rate endobronchial brachytherapy

Singh DP; Aujla K; Nead M; Bylund K.

J Clin Imaging Sci. 2021; 11: 45.

Utility of topical agents for radiation dermatitis and pain: a randomized clinical trial

Ryan Wolf J; Gewandter JS; Bautista J; Heckler CE; Strasser J; Dyk P; Anderson T; Gross H; Speer T; Dolohanty L; Bylund K; Pentland AP; Morrow GR.

Support Care Cancer. 2020; 28(7): 3303-3311.

Building a High-Dose-Rate Prostate Brachytherapy Program With Real-Time Ultrasound-Based Planning: Initial Safety, Quality, and Outcome Results

Zhang H; Kang S; Ali N; Baran A; Bylund K; Gentile D; Previte G; Matloubieh A; Gray A; Marou N.

Adv Radiat Oncol. 2020; 5(3): 388-395.

Prognostic Significance of Sites of Visceral Metastatic Disease in Prostate Cancer: A Population-based Study of 12,180 Patients

Budnik J; Suri J; Bates JE; Bylund KC; Milano MT.

Clin Genitourin Cancer. 2019; 17(4): 260-267.

A Festschrift in Honor of Edward M. Messing, MD, FACS.

Joseph JV; Brasacchio R; Fung C; Reeder J; Bylund K; Sahasrabudhe D; Yeh SY; Ghazi A; Fultz P; Rubens D; Wu G; Singer E; Schwarz E; Mohile S; Mohler J; Theodorescu D; Lee YF; Okunieff P; McConkey D; Rashid H; Chang C; Fradet Y; Guru K; Kukreja J; Sufrin G; Lotan Y; Bailey H; Noyes K; Schwartz S; Rideout K; Bratslavsky G; Campbell SC; Derweesh I; Abrahamsson PA; Soloway M; Gomella L; Golijanin D; Svatek R; Frye T; Lerner S; Palapattu G; Wilding G; Droller M; Trump D.

Bladder Cancer. 2018; 4(suppl 1): S1-S43.

Is there a subset of patients with recurrent cancer in the vagina who are not candidates for interstitial brachytherapy that can be treated with multichannel vaginal brachytherapy using graphic optimization?

Singh DP, Bylund KC, Matloubieh A, Mazloom A, Gray A, Sidhu R, Barrette L, Chen Y

Journal of contemporary brachytherapy.. 2015 April 7 (2):135-41. Epub 04/28/2015.

Bladder cancer in the elderly patient: challenges and solutions.

Guancial EA, Roussel B, Bergsma DP, Bylund KC, Sahasrabudhe D, Messing E, Mohile SG, Fung C

Clinical interventions in aging.. 2015 10 :939-49. Epub 06/10/2015.

Split-course palliative radiotherapy for advanced non-small cell lung cancer.

Metcalfe SK, Milano MT, Bylund K, Smudzin T, Rubin P, Chen Y

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.. 2010 February 5 (2):185-90. Epub 1900 01 01.

Analysis of interfraction prostate motion using megavoltage cone beam computed tomography.

Bylund KC, Bayouth JE, Smith MC, Hass AC, Bhatia SK, Buatti JM

International journal of radiation oncology, biology, physics.. 2008 November 172 (3):949-56. Epub 1900 01 01.

Real-time sonoelastography of hepatic thermal lesions in a swine model.

Zhang M, Castaneda B, Christensen J, Saad W, Bylund K, Hoyt K, Strang JG, Rubens DJ, Parker KJ

Medical physics.. 2008 September 35 (9):4132-41. Epub 1900 01 01.

Soft tissue sarcoma in the setting of chronic cutaneous graft versus host disease after allogenic bone marrow transplantation.

Bylund KC, Giampoli E, Singh D, Doerr T, Sahasrabudhe D, Liesveld J, Constine LS

Cancer investigation.. 2008 July 26 (6):638-41. Epub 1900 01 01.

Books

Reference Module in Biomedical Sciences (2016)

Chapter: 7-Benzylidine-7-Dehydronaltrexone

Reference Module in Biomedical Sciences (2015)

Chapter: Endometrial Cancer

Reference Module in Biomedical Sciences (2015)

Chapter: Testicular Cancer

Reference Module in Biomedical Sciences (2015)

Chapter: Difenoxin

Advances in Radiation Oncology in Lung Cancer (2011)

Chapter: Translational Research in Lung Cancer

Ratings & Comments

At URMC, we believe that patients should be empowered to make the right decisions regarding their personal healthcare. To do so, transparency is critical. URMC partners with Press Ganey, to survey our patients about all aspects of their care experience. We are now putting this pertinent information at your fingertips by displaying star ratings for our providers along with anonymous patient comments on our website. This will help you make better-informed choices about how and with whom you seek care. Click here to learn more about the surveys used to generate this vital information. Learn more about our survey process.

Ratings

Care provider's discussion of any proposed treatment (options, risks, benefits, etc.)

4.9 stars

Likelihood of recommending this care provider to others

4.9 stars

Explanations the care provider gave you about your problem or condition

4.9 stars

Care provider's efforts to include you in decisions about your care

4.9 stars

Concern the care provider showed for your questions or worries

4.9 stars

Patient Comments

5.0 stars

Assistance as always been well provided with proper attention

Dec 28, 2024

5.0 stars

Dr Bylund and his Resident are both fantastic - professional, courteous, and focused on the patient. [...] was/is my angel of light, through a sometimes shadowy path!

Dec 27, 2024

5.0 stars

Listen to me very well

Dec 26, 2024

5.0 stars

I didn't have any questions for my doctor just expressed my gratitude for his care.

Nov 17, 2024

5.0 stars

Dr. Bylund is an excellent physician.

Nov 13, 2024

5.0 stars

I had appointments [...] with both Dr. Suhasrabudhe and Dr. Bylund. These answers apply to both. Yes, both provider's involved me in their decision processing - I feel that I was heard.

Oct 28, 2024

5.0 stars

Doctor Byland and his resident are very professional, accommodating, informative, empathetic, and positive.

Oct 26, 2024

5.0 stars

I actually have recommended Dr Bylund to others. Very good Dr. I feel safe in his care.

Oct 22, 2024

4.0 stars

I spoke with a radiation oncologist. Naturally his answers were limited primarily to this field. However, he was able to refer me to a medical oncologist for answers to the questions he could not answer.

Oct 21, 2024

5.0 stars

Excellent explanation of situation and how we will handle it.

Sep 24, 2024